Roche Holding AG Stock Swiss Exchange
Stocks
ROG
CH0012032048
Pharmaceuticals
OTC Markets Traded|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 334.90 CHF | -1.35% |
|
+2.01% | +2.04% |
| 01:40am | Roche's Gazyva/Gazyvaro Lands Priority Review From US FDA in Nephropathy | MT |
| Jul. 14 | Swiss Market Index Slips; Roche Shares Down | MT |
| Market Cap | 261B 323B 282B 241B 454B 31,020B 462B 3,111B 1,221B 15,189B 1,213B 1,186B 52,301B | P/E 2026 * |
17.5x | P/E 2027 * | 16.3x |
|---|---|---|---|---|---|
| Enterprise Value | 271B 336B 294B 251B 472B 32,275B 481B 3,237B 1,270B 15,804B 1,262B 1,234B 54,417B | EV / Sales 2026 * |
4.34x | EV / Sales 2027 * | 4.06x |
| Free-Float |
88.78% | Yield 2026 * |
3.06% | Yield 2027 * | 3.14% |
Last Transcript: Roche Holding AG
| 1 day | -1.35% | ||
| Current month | +3.91% | ||
| 6 months | -1.33% | ||
| Current year | +2.04% |
| Current year | 315.6 |  | 374.9 |
| 1 year | 243.9 | | 374.9 |
| 3 years | 212.9 | | 374.9 |
| 5 years | 212.9 | | 404.2 |
| 10 years | 206.35 | | 404.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 51 | 2023-03-14 | |
Alan Hippe
DFI | Director of Finance/CFO | 59 | 2011-06-05 |
| Chief Operating Officer | - | 2025-09-30 |
| Director | Title | Age | Since |
|---|---|---|---|
André Hoffmann
BRD | Director/Board Member | 68 | 1995-12-31 |
Severin Schwan
CHM | Chairman | 59 | 2023-03-14 |
| Director/Board Member | 73 | 2015-03-02 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.35% | +2.01% | - | - | 323B | |
| -2.48% | -6.72% | +44.19% | +156.43% | 1,028B | |
| -1.52% | -5.01% | +61.87% | +58.79% | 611B | |
| -1.30% | -3.88% | +27.81% | +79.97% | 432B | |
| -0.65% | -3.19% | +26.88% | +43.52% | 277B | |
| +0.15% | -12.93% | +18.13% | +21.56% | 257B | |
| +0.75% | -0.26% | -25.58% | -39.87% | 217B | |
| -1.44% | -3.49% | +19.60% | +56.20% | 192B | |
| -1.04% | -4.63% | +16.01% | +68.47% | 161B | |
| -0.94% | +0.75% | -4.34% | -33.23% | 138B | |
| Average | -0.55% | -4.75% | +20.51% | +45.76% | 368.18B | |
| Weighted average by Cap. | -0.50% | -5.43% | +32.46% | +77.71% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 62.61B 77.5B 67.72B 57.84B 109B 7,444B 111B 747B 293B 3,645B 291B 285B 12,551B | 65.26B 80.79B 70.6B 60.3B 114B 7,760B 116B 778B 305B 3,800B 303B 297B 13,083B |
| Net income | 15.22B 18.85B 16.47B 14.07B 26.49B 1,810B 26.97B 182B 71.24B 886B 70.79B 69.23B 3,052B | 16.35B 20.24B 17.68B 15.1B 28.44B 1,944B 28.96B 195B 76.49B 952B 76.01B 74.33B 3,277B |
| Net Debt | 10.56B 13.07B 11.42B 9.75B 18.36B 1,255B 18.7B 126B 49.39B 615B 49.08B 47.99B 2,116B | 3.92B 4.85B 4.24B 3.62B 6.81B 466B 6.94B 46.69B 18.32B 228B 18.2B 17.8B 785B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- ROP Stock
- ROG Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
